[1]买志福,杨 波,蔡小玲,等.血小板与癌症的研究进展[J].现代检验医学杂志,2018,33(05):161-164.[doi:10.3969/j.issn.1671-7414.2018.05.045]
 MAI Zhi-fu,YANG Bo,CAI Xiao-ling,et al.Research Progress on the Interaction between Platelets and Cancer[J].Journal of Modern Laboratory Medicine,2018,33(05):161-164.[doi:10.3969/j.issn.1671-7414.2018.05.045]
点击复制

血小板与癌症的研究进展()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年05期
页码:
161-164
栏目:
综述
出版日期:
2018-11-18

文章信息/Info

Title:
Research Progress on the Interaction between Platelets and Cancer
文章编号:
1671-7414(2018)05-161-04
作者:
买志福1杨 波12蔡小玲1哈小琴1
1.兰州军区兰州总医院检验科,兰州 730050; 2.甘肃中医药大学,兰州 730000
Author(s):
MAI Zhi-fu1YANG Bo12CAI Xiao-ling1HA Xiao-qin1
1.Department of Clinical Laboratory, Lanzhou General Hospital of Lanzhou Military Area Command,Lanzhou 730050,China; 2.Gansu University of Chinese Medicine,Lanzhou 730000,China
关键词:
血小板 癌症 静脉血栓栓塞 抗血小板药物
分类号:
R730.4
DOI:
10.3969/j.issn.1671-7414.2018.05.045
文献标志码:
A
摘要:
血小板的主要功能已经被认可超过一个世纪,但是越来越多的实验和临床证据证明血小板也是重要的癌症中间介质。癌症的确影响血小板生理特性,激活的血小板通过促进肿瘤生长、血管生成、转移和癌症相关血栓形成而参加癌症发展的每个过程。根据血小板参与癌症进展和众多实验模型以及用抗血小板药物预防癌症的流行病学研究的结果,提出血小板是降低短期癌症风险、癌症传播和癌症死亡率的潜在靶点。因此,血小板对癌症和癌症的发展需要得到进一步的肿瘤界的重视,并且需要越来越多的实验去证实其联合其他抗癌药物的临床效果。
Abstract:
The main function of platelets has been recognized for more than a century,but more and more experimental and clinical evidenceprove that platelets are also an important mediator of cancer.Cancer does affect the physiological characteristics of platelets,and activated platelets participate in every process of cancer development by promoting tumor growth,angiogenesis,metastasis and cancer-associated thrombosis.Based on the results of platelet involvement in cancer progression and numerous experimental models and epidemiological studies of the prevention of cancer with anti-platelet drugs,it was suggested that platelets are potential targets for reducing short-term cancer risk,cancer spread and cancer mortality.Therefore,platelets on the development of platelets on cancer and cancer needs further attention in the tumor field,and more and more experiments are needed to confirm their clinical effect in combination with other anti-cancer drugs.

参考文献/References:

[1] Gasic GJ,Gasic TB,Stewart CC.Antimetastatic effe-cts associated with platelet reduction[J].Proc Natl Acad Sci USA,1968,61(1):46-52.
[2] Jin K,Li T,van Dam H,et al.Molecular insights into tumour metastasis: tracing the dominant events[J].The Journal of Pathology,2017,241(5):567-577.
[3] 马 睿,任 静,门剑龙.血栓风险标志物在癌症相关静脉血栓栓塞症监测中的研究进展[J].临床检验杂志,2017,35(12):942-945.
Ma R,Ren J,Men JL.Research progress of thrombus risk markers in the monitoring of cancer-related venous thromboembolism[J].Chinese Journal ofClinical Laboratory Science,2017,35(12):942-945.
[4] Meikle CKS,Kelly CA,Garg P,et al.Cancer and thrombosis:the plateletperspective[J].Frontiers in Cell and Developmental Biology,2017,4:147.
[5] Johnson KE,McAllister SS,Italiano JE,et al.The role of platelets in the tumor microenvironment[M]//Biomarkers of the Tumor Microenvironment:Basic Studies and Practial Applications.Springer:Cham,2017:281-302.
[6] Mezouar S,Mege D,Darbousset R,et al.Involvement of platelet-derivedmicroparticles in tumor progression and thrombosis[J].Semin Oncol,2014,41(3):346-358.
[7] Tranum BL,Haut A.Thrombocytosis:platelet kinetics in neoplasia[J].The Journal of Laboratory and Clinical Medicine,1974,84(5):615-619.
[8] Levin J,Conley CL.Thrombocytosis associated with malignant disease[J].Archives of Internal Medicine,1964,114(4):497-500.
[9] Wang H,Gao J,Bai M,et al.The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer[J].Platelets,2014,25(5):382-387.
[10] Zhou Q,Huang F,He Z,et al.Clinicopathological and prognosticsignificance of platelet count in patients with ovarian cancer[J].Climacteric,2018,21(1):60-68.
[11] Lin RJ,Afshar-Kharghan V,Schafer AI.Paraneoplastic thrombocytosis:the secrets of tumor self-promotion[J].Blood,2014,124(2):184-187.
[12] Yan MJ,Jurasz P.The role of platelets in the tumor microenvironment:From solid tumors to leukemia[J].Biochimicaet Biophysica Acta(BBA)-Molecular Cell Research,2016,1863(3):392-400.
[13] Roswall P,Bocci M,Bartoschek M,et al.Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling[J].Nature Medicine,2018,24(4):463-471.
[14] Zhang M,Liu T,Xia B,et al.Platelet-derived growth factor D is a prognostic biomarker and is associated with platinum resistance in epithelial ovarian cancer[J].International Journal of Gynecological Cancer,2018,28(2):323-331.
[15] Wang Z,Huang H.Platelet factor-4(CXCL4/PF-4): an angiostatic chemokine for cancer therapy[J].Cancer Letters,2013,331(2):147-153.
[16] Adams JM,Cory S.The BCL-2 arbiters of apoptosis and their growing role as cancer targets[J].Cell Death and Differ,2018,25(1):27-36.
[17] Velez J,Enciso LJ,Suarez M,et al.Platelets promote mitochondrial uncoupling and resistance to apoptosis in leukemia cells:a novel paradigm for thebone marrow microenvironment[J].Cancer Microenvironment,2014,7(1-2):79-90.
[18] Jurasz P,Alonso-Escolano D,Radomski MW.Platelet-cancer interactions:mechanisms and pharmacology of tumour cell-induced platelet aggregation[J].British Journal of Pharmacology,2004,143(7):819-826.
[19] Walraven M,Homs MYV,van der Veldt AAM,et al.Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib,but unaffected bybevacizumab[J].Angiogenesis,2018,21(2):325-334.
[20] Kisucka J,Butterfield CE,Duda DG,et al.Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage[J].Proceedingsof the National Academy of Sciences of the United States of America,2006,103(4):855-860.
[21] Kut C,Mac Gabhann F,Popel AS.Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer[J].British Journal of Cancer,2007,97(7):978-985.
[22] Gay LJ,Felding-Habermann B.Contribution of pla-telets to tumour metastasis[J].Nature Reviews Cancer,2011,11(2):123-134.
[23] Stegner D,Dütting S,Nieswandt B.Mechanistic explanation for plateletcontribution to cancer metastasis[J].Thrombosis Research,2014,133(Suppl 2):S149-S157.
[24] Rachidi S, Metelli A,Riesenberg B,et al.Platelets subvert T cell immunity against cancer via GARP-TGFβ axis[J].Science Immunology,2017,2(11):eaai7911.
[25] Leblanc R,Peyruchaud O.The role of platelets and megakaryocytes in bone metastasis[J].Journal of Bone Oncology,2016,5(3):109-111.
[26] Jackson W,Sosnoski DM,Ohanessian SE,et al.Role of megakaryocytes inbreast cancer metastasis to bone[J].Cancer Research,2017,77(8):1942-1954.
[27] Ay C,Simanek R,Vormittag R,et al.High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients:results fromthe Vienna Cancer and Thrombosis Study(CATS)[J].Blood,2008,112(7):2703-2708.
[28] Mutlu H,Artis TA,Erden A,et al.Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis[J].Clinical and Applied Thrombosis/Hemostasis,2013,19(3):331-333.
[29] 宋 伟,明章银.血小板在静脉血栓形成及诊断中的作用研究进展[J].中国药理学通报,2017,33(7):889-892.
Song W,Ming ZY.Research progress on role of platelets in development anddiagnosis of venous thrombosis[J].Chinese Pharmacological Bulletin,2017,33(7):889-892.
[30] Kolenich JJ,Mansour EG,Flynn A.Haematological effects of aspirin[J].The Lancet,1972,2(7779):714.
[31] Wood S,Hilgard P.Aspirin and tumour metastasis[J].The Lancet,1972,2(7792):1416-1417.
[32] 曹 文,周小青.中药有效成分丹参酮IIA,三七总苷与阿司匹林抗结直肠癌机制的研究现状及展望[J].湖南中医药大学学报,2018,38(1):110-114.
Cao W,Zhou XQ.Research status and prospects of tanshinone IIA,panax notoginseng saponins and aspirin on anti-colorectal cancer[J].Journal of Hunan University of Chinese Medicine,2018,38(1):110-114.

相似文献/References:

[1]王培昌,郑宇佳,高世超.血细胞分析仪未检出血小板分布宽度的原因分析及该类标本血小板计数准确性评价[J].现代检验医学杂志,2016,31(01):117.[doi:10.3969/j.issn.1671-7414.2016.01.034]
 WANG Pei-chang,ZHENG Yu-jia,GAO Shi-chao.Analysis of the Causes on PDW Results Disappeared in Automatic Hematology Analyzer and the Evaluation of Platelet Result[J].Journal of Modern Laboratory Medicine,2016,31(05):117.[doi:10.3969/j.issn.1671-7414.2016.01.034]
[2]苏晓丽a,刘媛,孙杨b,等.中国部分地区三级综合医院外科大量输血死亡组与非死亡组用血情况调研分析[J].现代检验医学杂志,2015,30(06):154.[doi:10.3969/j.issn.1671-7414.2015.06.047]
[3]李贞贞a,b,徐金梅a,等.血小板抗表皮葡萄球菌生长的研究[J].现代检验医学杂志,2016,31(05):42.[doi:10.3969/j.issn.1671-7414.2016.05.011]
 LI Zhen-zhena,b,XU Jin-meia,et al.Antibacterial Effect of Platelets on Staphylococcus Epidermidis[J].Journal of Modern Laboratory Medicine,2016,31(05):42.[doi:10.3969/j.issn.1671-7414.2016.05.011]
[4]杨祥丽,王佃鹏,李培茂,等.阶梯式离心法血小板提取及鉴定方法的建立[J].现代检验医学杂志,2017,32(02):135.[doi:10.3969/j.issn.1671-7414.2017.02.037]
 YANG Xiang-li,WANG Dian-peng,LI Pei-mao,et al.Isolation and Identification of Platelet by Stepped Centrifugal Method[J].Journal of Modern Laboratory Medicine,2017,32(05):135.[doi:10.3969/j.issn.1671-7414.2017.02.037]
[5]乔国昱,何亚萍,周 洁.妊娠期糖尿病并发甲状腺功能减退孕妇凝血功能指标的变化研究[J].现代检验医学杂志,2017,32(03):109.[doi:10.3969/j.issn.1671-7414.2017.03.029]
 QIAO Guo-yu,HE Ya-ping,ZHOU Jie.Study on the Alteration of Blood Coagulation Function of PregnantWomen with Pothyroidism Companied with Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(05):109.[doi:10.3969/j.issn.1671-7414.2017.03.029]
[6]李家明,唐伍涛,李欣霏,等.四川攀枝花地区健康成年体检人群外周血血小板及其相关参数生物参考区间的建立与评价[J].现代检验医学杂志,2021,36(02):122.[doi:doi:10.3969/j.issn.1671-7414.2021.02.029]
 LI Jia-ming,TANG Wu -tao,LI Xin -fei,et al.Establishment and Evaluation of Peripheral Blood Platelets and Its Related Parameters in Healthy Adult Physical Examination Population in Panzhihua Region Sichuan Province[J].Journal of Modern Laboratory Medicine,2021,36(05):122.[doi:doi:10.3969/j.issn.1671-7414.2021.02.029]
[7]秦 云.肺炎患者血液PLT,PA/Fig和NGAL联合检测在不同类型病原菌感染鉴别及疗效评估中的价值[J].现代检验医学杂志,2021,36(05):83.[doi:10.3969/j.issn.1671-7414.2021.05.019]
 QIN Yun.Value of Combined Detection of PLT, PA/Fig and NGAL in the Blood ofPatients with Pneumonia in the Identification of Different Types ofPathogenic Infections and the Evaluation of Therapeutic Effects[J].Journal of Modern Laboratory Medicine,2021,36(05):83.[doi:10.3969/j.issn.1671-7414.2021.05.019]
[8]谭 雍,严 敏,程 珍,等.433例肺血栓栓塞症患者血液 C-反应蛋白、抗凝血酶和纤维蛋白原及血液学变化特点分析[J].现代检验医学杂志,2022,37(01):203.[doi:10.3969/j.issn.1671-7414.2022.01.042]
 TAN Yong,YAN Min,CHENG Zhen,et al.Analysis of Change Feature of CRP ,Antithrombin, Fibrinogen and Hematological Indexs in 433 Patients with PulmonaryThromboembolism[J].Journal of Modern Laboratory Medicine,2022,37(05):203.[doi:10.3969/j.issn.1671-7414.2022.01.042]

备注/Memo

备注/Memo:
基金项目:江苏省科技专项基金(SBA2016020050)。
作者简介:买志福(1987-),男,本科,主管技师,研究方向:临床血液学。
通讯作者:哈小琴,博士,主任医师,硕士生导师,E-mail:haxiaoqin2013@163.com。
更新日期/Last Update: 2018-09-30